Nuvation Bio Inc. Class A Common Stock vs RingCentral Inc. Class A Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while RingCentral Inc. Class A Common Stock trades at $78.58 (market cap $6.54B). The key difference: RingCentral Inc. Class A Common Stock is far larger — about 3.8× Nuvation Bio Inc. Class A Common Stock's market cap, and RingCentral Inc. Class A Common Stock pays a 0.35% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and RingCentral Inc. Class A Common Stock for 0 Days on average.
| NUVB | RNG | |
|---|---|---|
Market Cap | $1.74B | $6.54B |
Volume | 9,289,619 | 1,543,570 |
Sector | Health | Technology |
52-Week High | $9.54 | $79.82 |
52-Week Low | $3.41 | $24.82 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.33B | $7.60B |
Dividend Yield | — | 0.35% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.
Read more on RNG →